在COPD恶化中评估卡利斯塔丁水平
Kadir Burak Akgün1, Serdar Doğan2, Nursel Dikmen3
1Department of Pulmonology, Faculty of Medicine, Hatay Mustafa Kemal University, Antakya, Hatay, Türkiye.
Canadian respiratory journal
|June 20, 2025
概括
卡利斯塔丁水平在COPD患者和恶化期间较低,这表明它可能是识别慢性阻塞性肺病 (COPD) 和其爆发的生物标志物.
科学领域:
- 生物化学 生化学
- 肺部病理学 肺部病理学
- 生物标志物发现发现
背景情况:
- 卡利斯塔丁具有抗氧化和抗炎性质.
- 它提供了对ARDS和肺纤维化等疾病的保护.
- 这项研究调查了kalistatin在慢性阻塞性肺病 (COPD) 中的作用.
研究的目的:
- 评估COPD患者在稳定期和恶化期的血清卡利斯塔丁水平.
- 为了比较COPD患者和健康个体之间的卡利斯塔丁水平.
- 探索卡利斯塔丁与COPD中其他氧化应激标志物之间的相关性.
主要方法:
- 血清卡利斯塔丁,TAS,TOS,OSI,VEGF和TNF-α水平测量了48名COPD患者和30名健康对照.
- 对稳定,恶化和对照组进行了统计分析.
- 对有意义的血清参数进行了相关性和回归分析.
主要成果:
- 慢性肺炎患者的血清卡利斯塔丁水平明显低于健康人群 (p < 0.001).
- 与稳定时期相比,在COPD恶化期间,卡利斯塔丁水平进一步降低 (p < 0.001).
- 卡利斯塔丁在恶化期间与OSI和VEGF有正相关性,与OSI有很强的回归联系.
结论:
- 卡利斯塔丁作为一种潜在的生物标志物,可以将COPD患者与健康个体区分开来.
- 较低的卡利斯塔丁水平表明COPD患者的疾病恶化.
- 卡利斯塔丁与氧化应激标志物的关联需要在COPD管理方面进一步调查.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.6K
COPD: Management Using Bronchodilators and Corticosteroids
329
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
329
COPD: Pathogenesis and Clinical Features
540
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
540
Sputum Studies I: Gram Stain, cytology, and Acid-fast smear and culture
304
Sputum studies are a critical part of diagnosing and treating numerous respiratory conditions. These studies involve obtaining sputum samples for analysis to identify pathogenic organisms and assess the presence of abnormal cells indicative of malignant conditions. This lesson will delve into three fundamental sputum studies: Gram Stain, Cytology, and Acid-fast Smear and Culture.
Gram Stain
The Gram Stain is an integral part of sputum studies. It involves the staining of sputum, which permits...
Gram Stain
The Gram Stain is an integral part of sputum studies. It involves the staining of sputum, which permits...
304
Chronic Obstructive Pulmonary Disease-I: Introduction
3.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.0K
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K


